Compare CLBK & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLBK | INVA |
|---|---|---|
| Founded | 1927 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2017 | 2000 |
| Metric | CLBK | INVA |
|---|---|---|
| Price | $17.96 | $23.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $17.00 | ★ $32.80 |
| AVG Volume (30 Days) | 179.3K | ★ 563.1K |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 563.64 | ★ 816.67 |
| EPS | 0.51 | ★ 3.30 |
| Revenue | N/A | ★ $217,217,000.00 |
| Revenue This Year | $3.97 | $8.95 |
| Revenue Next Year | $11.43 | $12.65 |
| P/E Ratio | $36.15 | ★ $7.25 |
| Revenue Growth | N/A | ★ 62.63 |
| 52 Week Low | $13.56 | $16.52 |
| 52 Week High | $18.87 | $25.15 |
| Indicator | CLBK | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 53.72 |
| Support Level | $17.82 | $19.16 |
| Resistance Level | $18.71 | $25.15 |
| Average True Range (ATR) | 0.32 | 0.61 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 47.23 | 47.06 |
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.